Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Duodenal ulcer
ADR ID BADD_A01350
ADR Hierarchy
07      Gastrointestinal disorders
07.04      Gastrointestinal ulceration and perforation
07.04.02      Duodenal ulcers and perforation
07.04.02.002      Duodenal ulcer
Description A disorder characterized by a circumscribed, erosive lesion on the mucosal surface of the duodenal wall. [CTCAE] A PEPTIC ULCER located in the DUODENUM. | Acute stress DUODENAL ULCER, usually observed in patients with extensive third-degree burns. [MeSH]
MedDRA Code 10013836
MeSH ID D004381
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Acute duodenal ulcer | Acute duodenal ulcer without mention of haemorrhage or perforation | Acute duodenal ulcer without mention of hemorrhage or perforation | Acute duodenal ulcer without mention of hemorrhage or perforation, without mention of obstruction | Chronic duodenal ulcer without mention of haemorrhage or perforation | Chronic duodenal ulcer without mention of hemorrhage or perforation | Chronic duodenal ulcer without mention of hemorrhage or perforation, without mention of obstruction | DU | Duodenal ulcer | Duodenal ulcer aggravated | Duodenal ulcer reactivated | Duodenal ulcer, unspec as acute or chronic, w/o hemorrhage or perforation, w/o ment of obstruction | Duodenal ulcer, unspecified as acute or chronic, without mention of haemorrhage or perforation | Duodenal ulcer, unspecified as acute or chronic, without mention of hemorrhage or perforation | Reactivated DU | Reactivated duodenal ulcer | Ulcer duodenal | Ulcer duodenal reactivated | Chronic duodenal ulcer without mention of haemorrhage or perforation, without mention of obstruction | Duodenal Ulcer | Duodenal Ulcers | Ulcer, Duodenal | Ulcers, Duodenal | Curling Ulcer | Ulcer, Curling | Curling's Ulcer | Curlings Ulcer
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02254Tramadol--
BADD_D02270Tretinoin--
BADD_D02321Ursodiol--
BADD_D02325Valdecoxib--
BADD_D02331Valsartan0.000132%
BADD_D02344Vemurafenib0.000112%
BADD_D02365Vismodegib0.000168%
BADD_D02373Warfarin0.000452%
BADD_D02379Zaleplon--
BADD_D02470Nintedanib0.000168%
BADD_D02487Baricitinib0.000362%
BADD_D02489Neratinib0.000112%
The 5th Page    First    Pre   5    Total 5 Pages